HR Execs on the Move

Surterra

www.surterra.com

 
OUR MISSION: We believe that wellness is a pursuit and that nature has the ability to empower our health now and in the future.. It is our mission to provide the safest, highest quality cannabis-based products that empower your health and enable you and your loved ones to live well. OUR STORY: This past decade has seen a powerful shift in the way we define healthy living. From greater access to naturally-grown, organic foods to the awareness of the dangers in overly-processed, chemically-dependent products, communities everywhere are rediscovering what it means to live well. Surterra Wellness believes that this push ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.surterra.com
  • 1175 Peachtree Street 10th Floor
    Atlanta, GA USA 30361
  • Phone: 850.391.5455

Executives

Name Title Contact Details
Shannon Walker
Director of Human Resources Profile
Stevens Sainte-Rose
Chief Human Resources Officer Profile

Similar Companies

Community Care Inc

Community Care Inc is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Juva Life

Juva Life is working to bring the cannabis market face to face with the sector`s next generation investment grade business model.

Medical DecisionPoint

Medical DecisionPoint is a Montvale, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kidsvision

Kidsvision is a Jackson, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.